RARE
NASDAQ · Biotechnology
Ultragenyx Pharmaceutical In
$27.44
+0.53 (+1.97%)
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| May 4, 2026 | Q2 FY2026 | $-1.50 | — | — | — | — |
| Feb 12, 2026 | Q1 FY2026 | $-1.13 | — | — | — | — |